Symbol="ARQT"
AssetType="Common Stock"
Name="Arcutis BiotherapeuticsÂ Inc"
Description="Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California."
CIK="1787306"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2945 TOWNSGATE ROAD, SUITE 110, WESTLAKE VILLAGE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="537445000"
EBITDA="-314116992"
PERatio="None"
PEGRatio="None"
BookValue="2.277"
DividendPerShare="0"
DividendYield="0"
EPS="-5.65"
RevenuePerShareTTM="0.112"
ProfitMargin="0"
OperatingMarginTTM="-48.75"
ReturnOnAssetsTTM="-0.53"
ReturnOnEquityTTM="-1.663"
RevenueTTM="6467000"
GrossProfitTTM="2932000"
DilutedEPSTTM="-5.65"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="45.38"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1385.79"
PriceToBookRatio="3.742"
EVToRevenue="1017.85"
EVToEBITDA="-2.448"
Beta="0.482"
num_52WeekHigh="27.4"
num_52WeekLow="7.25"
num_50DayMovingAverage="10.6"
num_200DayMovingAverage="14.59"
SharesOutstanding="61422000"
DividendDate="None"
ExDividendDate="None"
symbol="ARQT"
open="9.11"
high="9.58"
low="8.94"
price="9.30"
volume="1081697.00"
latest_trading_day="2023-07-06"
previous_close="9.29"
change="0.01"
change_percent="0.1076%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1229475"
Change_recent_avg="-0.06"
Delta_recent_avg="0.78"
Variance_recent_avg="0.39"
Change_ratio_recent_avg="-0.59"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0150.jpeg"
image_negative_thumbnail_id_2="123"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0053.jpeg"
image_neutral_thumbnail_id_1="529"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="961"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0123.jpeg"
image_positive_thumbnail_id_2="672"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
